Superorganism

What Superorganism does

Superorganism is a venture capital firm founded in 2022/2023 by Kevin Webb and Tom Quigley, structured as Superorganism Fund I, L.P., and headquartered across San Francisco and New York. The firm is the first VC dedicated exclusively to biodiversity, deploying pre-seed and seed equity investments of $250,000 to $500,000 into early-stage nature-tech startups. Its investment thesis is organized around three themes: Extinction Drivers (addressing agriculture, circular economy, cities, invasive species, and pollution), Climate x Biodiversity (adaptation, forests, MRV, oceans, soil, and wildfire), and Enabling Tech (AI, biomanufacturing, genomics, remote sensing, robotics, and fintech). The firm has invested in approximately 20 portfolio companies (targeting ~35) including Array Labs (3D satellite imagery), Spoor (AI wildlife monitoring), Ulysses (autonomous seagrass restoration), Funga (fungal microbiome rewilding), Inversa (leather from invasive species), Cecil (natural capital data infrastructure), Amini (environmental data for Africa), and Cambium Carbon (forest products supply chain). Portfolio companies have collectively raised over $100 million in follow-on capital.

The firm operates a lean core team of five — Managing Directors Webb and Quigley, Senior Associates Annie McCluskey and Everett Sanderson, and Head of Ecosystem Kit McDonnell — supplemented by an external mentors network spanning conservation organizations and technology companies. Beyond capital, Superorganism offers portfolio founders on-demand connections and operational support, and operates a job board (jobs.superorganism.com) and talent network to recruit operators into portfolio companies. The firm has pledged 10% of future fund profits to conservation efforts, positioning its economic model as a hybrid of venture returns and philanthropic impact.

The firm's revenue model is conventional venture capital economics applied to a thematic mandate: management fees on committed capital in Fund I (approximately $25.9 million in commitments closed in January 2026) plus future carried interest on portfolio exits. Investors include institutional and strategic LPs such as Cisco Foundation, Builders Vision (founded by Walmart heir Lukas Walton), AMB Holdings, Wedgetail (Cameron Adams/Canva), Understorey Ventures, Stray, and individual investors Jeff Jordan of Andreessen Horowitz and Mark Tercek. The firm does not develop proprietary technology itself but curates AI- and biotech-heavy nature-tech investments, targeting the $598-$824 billion annual biodiversity funding gap and the global $200 billion-per-year commitment by 140+ countries to reverse biodiversity loss by 2030.

Name

Superorganism

Legal name

Superorganism Fund I, L.P.

Website

https://superorganism.com

Company type

Private

Founded year

2023

Operating status

Operating

Headcount range

1–10 employees

Short description

Superorganism is a venture capital firm that makes $250K-$500K pre-seed and seed equity investments in early-stage nature-tech startups addressing biodiversity loss. Founded in 2022, it manages a $25.9M debut fund backed by institutional and strategic LPs.

Ownership category

akta.pro rank

Product category

Venture Capital

NAICS

All Other Financial Investment Activities (52399), Grantmaking Foundations (813211)

SIC

Investment Advice (6282)

akta.pro primary industry

Biodiversity, Conservation & Natural Capital Funds (FSANAJAG)

akta.pro secondary industries

Early-Stage Venture Capital (Series A/B) (FSANAAAB), Energy & Sustainability / Climate Growth Equity (FSANACAG), Environmental & Climate Grantmaking Foundations (BPAGAKAM)

Keywords

• Venture capital funding
• Biodiversity investing
• Nature-tech startups
• Early-stage venture
• Seed-stage capital

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Venture Capital Returns: Superorganism generates returns through equity investments in early-stage biodiversity and nature-tech startups. As a VC firm, they take equity stakes in portfolio companies and aim to generate returns when these companies succeed or get acquired. The firm also pledges 10% of future profits to conservation efforts.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Superorganism is a venture capital firm making pre-seed and seed-stage equity investments of $250,000 to $500,000 in early-stage nature-tech startups dedicated to biodiversity. Its $25.9 million debut Fund I backs founders across three themes: Extinction Drivers, Climate x Biodiversity, and Enabling Tech. The firm pledges 10% of future profits to conservation and supplements capital with a mentor network spanning conservation and entrepreneurship.

Product overview

Superorganism is the first venture capital firm dedicated to biodiversity, offering its debut Fund I at $25.9 million for early-stage nature-tech investments. The firm operates across three core investment themes: Extinction Drivers (startups addressing industries most responsible for biodiversity loss), Climate x Biodiversity (solutions that are win-wins for both climate and nature), and Enabling Tech (remote sensing, genomics, AI, drones, and robotics supporting conservation work). The portfolio spans 18 companies including Array Labs (3D satellite imagery), Spoor (AI wildlife monitoring), Ulysses (autonomous seagrass restoration), Funga (fungal microbiome rewilding), Inversa (luxury leather from invasive species), Cecil (natural capital data infrastructure), Amini (environmental data for Africa), Cambium Carbon (forest products supply chain), Planet A Foods (cocoa-free chocolate), and others focused on sustainable materials, bioremediation, and ecosystem restoration.

Differentiator

Problem solved

Functional benefit

Products and services

• Superorganism Fund I A $25.9 million debut venture capital fund dedicated to biodiversity, making pre-seed and seed-stage equity investments of $250,000 to $500,000 in nature-tech startups addressing biodiversity loss and the climate–biodiversity overlap. Available to qualified institutional and strategic investors as limited partners.

Quantifiable outcome

• Portfolio companies have collectively raised over $100 million in additional capital
• +2 more outcomes

Named customers20 records

Segments3 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability8 records

Scale indicators7 records

Recent moves1 record

Expansion highlights5 records

Direct peers

• Lowercarbon Capital: Early-stage venture firm investing in companies that reduce CO2 — the closest direct peer as a thematic climate/nature VC writing seed-stage checks into science-heavy startups.
• Congruent Ventures: Early-stage venture firm investing across climate tech, sustainability, and nature-based solutions; comparable stage, check size, and thesis to Superorganism's Enabling Tech and Climate x Biodiversity themes.
• At One Ventures: Early-stage VC investing in companies that regenerate the natural environment; directly comparable biodiversity/climate focus with similar seed-stage approach and portfolio overlap.
• Engine Ventures: Climate tech-focused seed and Series A investor (formerly Clean Energy Ventures); matches Superorganism's stage, geography, and thematic climate/nature mandate.
• Prime Movers Lab: Early-stage deep tech investor backing breakthrough science including biotech, climate, and enabling technologies; highly comparable to Superorganism's Enabling Tech thesis (genomics, robotics, biomanufacturing).
• Regeneration.VC: Early-stage climate and nature-tech investor with a portfolio overlapping Superorganism's biomanufacturing, materials, and nature-based solutions focus areas.
• Climate Capital: Climate-focused early-stage venture firm investing across mitigation, adaptation, and nature-based solutions; comparable stage and mission to Superorganism.

Broad incumbents

• Breakthrough Energy Ventures: Bill Gates-backed, multi-billion-dollar climate VC that increasingly invests in nature-tech and biodiversity-adjacent companies; a much larger incumbent competing for the same founders and LP mandate.
• Khosla Ventures: Large multi-stage VC with a substantial climate/sustainability and biotech practice that has invested in nature-adjacent categories; competes for the same founders and biodiversity LP dollars at greater scale.

Others

• Builders Vision: Mission-aligned investment firm founded by Walmart heir Lukas Walton; both an LP in Superorganism Fund I and a co-investor in nature/sustainability deals, making it a relevant ecosystem peer and potential partner.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/superorganismvc

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments22 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Superorganism